TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.0770
-0.0024 (-3.02%)
At close: Mar 13, 2026
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €7.25 million as of March 13, 2026. Its market cap has increased by 6.91% in one year.
Market Cap
7.25M
Enterprise Value
6.91M
Revenue
27.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 7.25M, a decrease of -83.20%. That is a compound annual growth rate of -17.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 7.25M | 18.10% |
| Dec 31, 2025 | 6.13M | -13.10% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermentalg | 36.87M |
| Advicenne | 27.06M |
| genOway Société anonyme | 22.31M |
| GenSight Biologics | 18.74M |
| Aelis Farma | 17.74M |
| NFL Biosciences | 14.22M |
| Poxel | 13.43M |
| Oncodesign Precision Medicine Société anonyme | 9.97M |